CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue:
Capitated revenue (Related parties comprised $150,479 and $97,438, and $335,383 and $107,747, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	$ 379,210	$ 163,927	$ 646,261	$ 291,643
Fee-for-service and other revenue (Related parties comprised $219 and $213, and $631 and $344, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	13,953	7,279	27,037	14,861
Total revenue	393,163	171,206	673,298	306,504
Operating expenses:
Third-party medical costs (Related parties comprised $115,975 and $70,555, and $249,819 and $76,943, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	291,816	112,040	486,862	197,353
Direct patient expense (Related parties comprised $64 and $448, and $1,488 and $1,223, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	43,782	22,554	78,069	40,333
Selling, general, and administrative expenses (Related parties comprised $1,600 and $1,133, and $3,112 and $1,939, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	46,574	21,859	81,422	42,843
Depreciation and amortization expense	7,945	3,977	13,791	7,362
Transaction costs and other (Related parties comprised $1,465 and $4,209, and $1,483 and $5,369, in the three months ended June 30, 2021 and 2020, and in the six months ended June 30, 2021 and 2020, respectively)	16,374	15,687	25,613	22,138
Total operating expenses	406,491	176,117	685,757	310,029
Loss from operations	(13,328)	(4,911)	(12,459)	(3,525)
Other income and expense:
Interest expense	(9,714)	(5,717)	(20,340)	(9,382)
Interest income (Related parties comprised $79 and $157, in the three months ended June 30, 2020, and in the six months ended June 30, 2020, respectively)	1	79	2	159
Loss on extinguishment of debt	(13,225)		(13,225)
Change in fair value of embedded derivative		(306)		(306)
Change in fair value of warrant liabilities	39,215		39,215
Other expense	(25)	(150)	(25)	(150)
Total other income (expense)	16,252	(6,094)	5,627	(9,679)
Net income (loss) before income tax benefit	2,924	(11,005)	(6,832)	(13,204)
Income tax benefit	2,023	19	1,309	32
Net income (loss)	4,947	(10,986)	(5,523)	(13,172)
Net loss attributable to non-controlling interests	(4,533)	$ 0	(15,003)	$ 0
Net income attributable to Class A common stockholders	$ 9,480		$ 9,480
Net loss per common share:
Net income per share to Class A common stockholders, basic	$ 0.06		$ 0.06
Net loss per share to Class A common stockholders, diluted	$ (0.03)		$ (0.03)
Weighted-average shares used in computation of earnings per share:
Basic	167,134,853		166,691,634
Diluted	168,884,315		167,571,198